Skip links

Emflaza® (deflazacort)

Full Name Emflaza® (deflazacort)
Drug Emflaza
Manufacturer PTC Therapeutics, Inc.
Route of Administration Oral
Site of Care Home or Healthcare Facility
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website